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Lethal trait A46, also known as bovine hereditary zinc deficiency, Adema disease, and hereditary parakeratosis, is an autosomal recessive
disorder first described in 1964, with a clinical presentation similar to that of acrodermatitis enteropathica (AE) in humans. The molecular basis of
the defect has not been previously identified. Recently, the basic defect in AE was found to lie in SLC39A4. We report the characterization of the
bovine ortholog of SLC39A4 and identification of a unique splice site variant within this gene in affected animals. The mutation leads to exon
skipping, leaving the coding region in frame. The gene product is predicted to lack two critical motifs, which lie in adjacent transmembrane
domains implicated in the formation of a pore responsible for the transport of zinc. While further functional studies are warranted, this unique
variant is likely to be responsible for the impaired zinc absorption in this disease.
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Acrodermatitis enteropathica; Lethal trait A46; Bovine hereditary zinc deficiencyZinc is an essential nutrient and plays a critical role in the
function of many biological processes as a cofactor of many
enzymes, transcription factors, and other critical molecules in
both the animal and the plant kingdoms [1]. Symptoms of zinc
deficiency in animals are similar across various species and
include diarrhea, skin lesions, immunodeficiency, and growth
retardation. Studies of zinc transport in plants, bacteria, yeast,
and other eukaryotes have culminated in the recent identifica-
tion of two major solute-linked carrier (SLC) gene families, the
ZnT (SLC30) and Zip (SLC39) families, with at least 9 ZnT and
15 Zip transporters being identified in human cells [1].☆ Sequence data from this article have been deposited with the GenBank Data
Library under Accession Nos. DQ336345, DQ336346, DQ336347, DQ336348,
and DQ336349.
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doi:10.1016/j.ygeno.2006.03.018Three mammalian genetic disorders have been known to
involve zinc transport, lethal milk syndrome (lm) in mice,
acrodermatitis enteropathica (AE) in humans (OMIM No:
201100), and bovine hereditary zinc deficiency (BHZD), also
known as lethal trait A46 (OMIA 000593), in cattle [2–4]. All of
these disorders display an autosomal recessive inheritance. Of
these, lethal milk syndrome, so named because pups of any
genotype suckled on lm/lm dams die before weaning, is caused
by a mutation in the SLC30A4 (ZnT4) gene [2], which appears to
be critical in the transport of zinc into the milk. Supplementation
of pups with zinc or nursing on foster dams alleviates the
symptoms, but adult mutant mice display abnormalities
including difficulty in righting, tail-spinning, and instability
when swimming, possibly due to the role of SLC30A4 in zinc
transport in the brain. Dramatic effects of zinc deficiency are also
observed in AE, a rare human disorder, in which affected infants
usually present with skin lesions and diarrhea, infections, and, if
diagnosis and intervention are delayed, growth retardation [5–
7]. Investigations by two groups, led by Gitschier at the
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Laboratoire d’Etude de l’AND, in Nantes, France [9],
concurrently identified mutations in SLC39A4 as being
responsible for the disorder. Supplementation of AE infants
with zinc in very large doses (2- to 10-fold the required daily
intake) has been extremely effective in treatment of this disorder
[10]. Interestingly, the identification of the central role of zinc in
AE and its subsequent treatment with zinc were furthered by the
observation of the similarity of the manifestations of AE with
those of both acquired [7] and hereditary zinc deficiency in cattle
[11,12]. Of note, successful treatment of parakeratosis in cattle
with zinc was reported in 1960 [13], 4 years before the hereditary
defect was described.
Bovine hereditary zinc deficiency, also known as lethal trait
A46, Adema disease, hereditary parakeratosis, and hereditary
thymus hypoplasia, was first described in 1964 [14], in Black
Pied Friesian cattle. Black Pied Friesian cattle descended from
two breeds, Black Pied Jutlands from Denmark and Friesians
from Holland [15], which serve as the ancestors to the Holstein
breed, the major breed involved in dairy production today. A
similar disorder has been more recently described in Shorthorn
cattle in the United States [16] and in Angus cattle in Australia
[17]. In their report of the mutation in AE, Wang et al. [8]
mention personal communications with Australian colleagues
indicating a defect in the orthologous gene in Angus cattle.
Detailed description of the findings in Angus cattle has not been
reported except for the claim of an undisclosed missense
mutation in this gene in Angus cattle, which was not present in
Friesian cattle, in an abstract [18].
The presenting symptoms of BHZD are diarrhea and skin
lesions, followed by secondary infections and death if left
untreated. However, prompt treatment of calves with oral zinc
alleviates all signs and leads to normal development. In our
earlier studies, detailed characterization of the disorder and the
establishment of a family for genetic studies were reported [19].
The pedigree established by embryo transfers is shown in Fig. 1.
The two affected bulls thus obtained (VYG-1 and VYG-3) were
raised to 2.5 years of age and semen was banked from them for
future studies. Our treatment protocol from birth to 2 years of age
was described [19]. The adult animals have beenmaintained on a
regimen of oral boluses of 45 g of elemental zinc administered asFig. 1. The pedigree of BHZD cattle established at Michigan State University.
VYG-0 died within 24 h of birth from pneumonia and could not be phenotyped
with regard to BHZD status.zinc acetate in gelatin capsules twice aweek.With this treatment,
the animals have all been free of clinical signs. When treatment
lapses of a few weeks have occurred unintentionally, i.e., due to
unavailability of the gelatin capsules, skin lesions appeared in
the perianal area and on the lower extremities and resolved
completely within 2–3 weeks of reinstating treatment. At the
moment, the oldest affected animal is a healthy 11-year-old
heifer, VYG-6.
In recent studies, we provided evidence that the locus
mapped to a region orthologous to that of AE in the human [20].
In the current study, we report the identification of a single base
change that results in a unique splice site mutation in the bovine
ortholog of SLC39A4 as an excellent candidate to be the
causative mutation in lethal trait A46, the classical BHZD.
Results
Primers that successfully amplified bovine cDNA and
genomic samples are shown in Table 1, along with the optimal
annealing temperatures. Reverse transcription-polymerase chain
reaction (RT-PCR) of the samples from affected animals with
primer set 3 (VYG1180/VYG1170) produced a band about
150 bp shorter than those from unaffected animals. Sequencing
of the amplified products revealed the affected sample to be
missing exactly 153 bp, corresponding to exon 10 of the human
SLC39A4 gene, with the resulting sequence being in frame.
Amplification of genomic DNA fragments containing the splice
junctions on both ends of this exon was carried out using primers
VYG1277/VYG1278 and VYG1298/VYG1299 as shown in
Table 1. The amplified fragments from normal and affected
samples were sequenced. The sequences were deposited in
GenBank (intron 9, Accession No. DQ336348, and intron 10,
Accession No. DQ226349). The corresponding sequences
between the affected and the normal were all identical except
for a single nucleotide change fromG toA identified in the splice
donor position of intron 10 in the affected animals as seen in Fig.
2. Inspection of the intron sequences of the normal genotype
indicated conformity to the GT/AG rule [21] and the presence of
a C-rich pyrimidine tract near the splice acceptor site.
The G to A mutation was predicted to result in the
generation of a FokI restriction enzyme recognition site. To
screen samples rapidly and reliably for this mutation using
PCR, an artificial introduction of restriction sites test [22] was
designed, incorporating an engineered cut site for FokI in one
of the primers to serve as an internal control for digestion
(primers VYG1336/VYG1337). As indicated in Table 2 and
shown in Fig. 3, this results in the generation of a diagnostic
band of 143 bp for the G allele and of 98 bp for the A allele,
with the obligate heterozygous animals showing both alleles.
Our archived samples from the two affected bulls (VYG-1 and
VYG-3) and three affected heifers and three obligate hetero-
zygotes conform to the expected band pattern. All of the 104
clinically normal Holsteins screened were found to be
homozygous for the G allele.
The remaining coding region of bovine SLC39A4 was
amplified using RT-PCR and sequenced from both normal and
affected animals. No further differences were identified and the
Table 1
Primers used in polymerase chain reaction and sequencing
Template Primer set Primer name Sequence (from 5′) Primer position Product
size (bp)
Annealing
temperature (°C)
Other PCR
conditions
cDNA 1 VYG1313F a CAGGCAAGCTCGGCCTAC 5′ UTR 803 58 10% DMSO
VYG1314Rb CTGTCGTCACTGTGGCTGTC Exon 4
cDNA 2 VYG1184F GTACTTCGTGGACTTTGTGTT Exon 3 479 56 —
VYG1187R ATGTAGTGGGAGGTGGTGCT Exon 6
cDNA 3 VYG1180F CTGAGAGGTACCTGTATGGC Exon 5–exon 6 980 d (827) 58 10% DMSO
VYG1170R c CAGAAGCTCTCAGAAGGCGA Exon 12–3′ UTR
Genomic DNA 4 VYG1277F GAGCCCGGAGCCCCGGAGAC Exon 9 200 65 10% DMSO
VYG1278R CACGGCGTCGCCCAAAGTGAT Exon 10
Genomic DNA 5 VYG1298F GGAACCGGCCGGGGCAAATACG Intron 9 308 67 10% DMSO
VYG1299R GCCGCGCCCACTCCCCGATAGT Intron 10
Genomic DNA 6 VYG1214F AGCCCAAGCAGCTCCATGA Exon 8 1005 58 5% DMSO
VYG1189R AACGTAGAGGCCGATGAAGG Exon 11
a Primer designed based on sequence reported in GenBank trace sequence entry 410393809.
b Primer designed based on sequence reported in GenBank trace sequence entry 641547542.
c Primer designed based on sequence reported in GenBank entry AW477707.
d Product length from normal mRNA. In affected mRNA (length in parentheses) the product is lacking 153 nucleotides.
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No. DQ336345) along with that of the mutant (Accession No.
DQ336345). The aberrant message is in frame. The normal
bovine coding region shows about 80% identity with the human
at the nucleotide level. Alignment of the predicted bovine
protein with the human (GenBank Accession No. GI 19115957)
as optimized by ClustalW [23] using the DNA Star package
from Lasergene is shown in Fig. 4. The last four amino acids of
the bovine gene product are predicted from the primer, based on
a partial bovine cDNA, GenBank Accession No. AW47707,
and have not been independently verified. With that said, the
human and the bovine predicted proteins are 74% identical and
78% similar. The normal bovine product is predicted to have
653 amino acid residues compared to the normal human product
of 647 residues. The mutant transcript would code for a protein
lacking amino acids 498–548 as indicated in Fig. 4. This
deleted region is highly conserved, showing 92% identity
between the human and the bovine, and covers large parts of
two critical domains. All of transmembrane domain 4, which
contains the Zip motif (GDAVHNF), is deleted, as well as most
of transmembrane domain 5, including all but the last twoFig. 2. Radiolabeled dideoxynucleotide sequencing reaction products separated in a 6%
substitution (G to A) was discovered in the first position of intron 10 in affected anim
intron and explains the exon 10 skipping observed in cDNA from affected animals.amino acids of the HEXPHEXGD motif, identified as the
defining motif of the LZT family, LIV-1 subfamily of zinc
transporters [24]. These two domains appear to be critical in the
formation of a pore structure, which is proposed to be
potentially responsible for the transport of zinc ions [24].
Discussion
Our findings show that a single nucleotide mutation of the
splice donor site in intron 10 of the bovine SLC39A4 leads to a
unique transcript in the animals harboring the defective gene.
This mutation is predicted to have severe consequences for the
protein known to be involved in AE. The absence of this allele in
208 chromosomes from 104 Holsteins studied indicates that this
is not a common variant in Holsteins. In our search for this or a
similar variant, we did not find any transcripts from unaffected
individuals of any species that were missing exon 10. (Databases
searched include ESTs, nonredundant sequences in GenBank,
and other resources from the GeneCards interface.) Interestingly,
we identified three entries (BF685329, BQ432515, BM826539)
representing partial cDNAs containing a fragment matching theacrylamide sequencing gel and then exposed to X-ray film. A single nucleotide
als, indicated by the arrow. This destroys the conserved donor splice site of the
Table 2
Amplified fragment length polymorphism assay
Primer set a Annealing
temperature (°C)
PCR product
length (bp)
Restriction
enzyme b
Band sizes (bp) after
restriction digest c
G G/A A
Forward: VYG1336, 5′-GTGTTCTGCCACGAGGTGCC 61 164 FokI 143 143 —
(located in exon 10 of bovine ZIP4) — 98 98
Reverse: VYG1337, 5′-GGCGGGGATGGGGTCAGTCAAGG — 45 45
(located in intron 10 of bovine ZIP4) 21 21 21
a Mutagenesis nucleotide is in bold and underlined (A replaces C). 10% DMSO is included in PCR.
b Prior to digestion, MgCl2 is added to the PCR mix to a final concentration of 10 mM.
c Diagnostic bands are in bold.
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mutation events in these tumors. These sequences represent
partial human cDNA entries (498–879 bp long) from tumors
(two from leiomyosarcoma cell lines from ATCC—possibly the
same source—and one described as being from a “lymphoblast-
like cell line” from ascites fluid from a gastric cancer patient).
The absence of transcripts lacking exon 10 in normal tissues of
any species studied to date, the high degree of conservation of
this exon, and the importance of the domains it encodes strongly
supports that this uncommon variant in Holsteins is likely to be
the causative mutation rather than a linked marker, although
functional studies will provide the conclusive proof.
This finding brings to full circle the utility of comparative
observations made in cattle that provided a simple, yet life-
saving, treatment for humans affected with this disorder.
Producers now can choose to eliminate animals carrying this
variant from their breeding stocks. While the frequency of
carriers of this gene is likely to be low in the current cattle gene
pool, the need for vigilant screening of bulls is accentuated by
the large contribution to the gene pool of popular bulls through
the use of artificial insemination. The experience with another
autosomal recessive disorder in Holstein cattle, leukocyteFig. 3. Agarose gel with PCR products and FokI-digested PCR products. Lanes:
1 and 7, 100 bp DNA ladder (New England Biolabs); 2, undigested PCR
product; 3, normal (G/G) FokI cut; 4, heterozygote (G/A) FokI cut; 5, affected
(A/A) FokI cut; 6, negative control (water blank) for PCR and digest. Table 2
lists band sizes for each genotype.adhesion deficiency, provides a good example [25]. The
mutation is in the gene coding for CD18, the common β
subunit of the β2 integrins in both humans and cattle [26]. In
this disorder, deficiencies in leukocyte function lead to death of
calves due to infections. With the identification of the mutation,
population studies were able to be carried out in 1992, revealing
the carrier frequency of the mutation in bulls and cows to be 15
and 9%, respectively, and showing all the cattle with the mutant
allele to be related to the same bull [27]. While subsequent
studies revealed the mutant allele to have spread throughout the
world, as recently reviewed [28], there has been a dramatic
decline in the frequency of this disorder with the use of genetic
testing by the Holstein breeders and the dairy industry. It is
possible that some of the remaining calf morbidity and mortality
in Holsteins is attributable to BHZD and may be controlled by
genetic testing.
The splice donor site mutation identified in this study has
not been reported in any of the human cases studied to date.
Over 25 mutations have been described in SLC39A4 in
humans. Of these, 3 involve splicing abnormalities. One
mutation is that of c.192 + 19G→ A [9], which creates a false
splice site. Two other mutations involve abolition of a splice
site. One of these, c.475−2A→ G, leads to skipping of exon 2
and is predicted to result in a frameshift [29] and a premature
stop codon. The other (c.1150−2A → G), which has been
described [8,29], is a splice-acceptor mutation that changes the
AG preceding exon 7 to GG. It is possible that future studies
will identify other splicing defects. The present finding adds to
the importance of the GT/AG splice donor–splice acceptor
consensus sequences in introns in bovine mRNA processing,
as is the case in humans.
We propose that BHZD will be useful not only for the study
of the inherited disorder of zinc deficiency, but also of zinc
deficiency in general, including the more subtle effects of
marginal zinc deficiency on the immune system. The availabil-
ity of a growing list of genomic resources for the bovine will
make possible highly sophisticated studies. As many transcrip-
tion factors rely on zinc for their activity, we hypothesize that
changes in gene expression are a major target for complications
of marginal zinc deficiency, which may be prevalent in both
underdeveloped and developing countries as well as in
segments of the population such as the elderly in the developed
world [30]. The availability of a growing number of genomic
resources, including microarrays, will allow us to use this model
Fig. 4. ClustalW alignment of the predicted bovine and human SLC39A4 gene product. The underlined residues are predicted to be the signal peptide. The
transmembrane domains (TM-1 to TM-8) are indicated by the boxed sequences. The core residues that make up the Zip and HEXPHEXGDmotifs, in TM-4 and TM-5,
respectively, are indicated in bold. The shaded residues correspond to exon 10, the region deleted in the mutant transcripts. The last four amino acids of the bovine
sequence are predicted from a primer based on GenBank entry AW477707 and have not been independently sequenced by us.
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deficiency on the transcription of many genes across different
organ and cellular systems and to make further contributions to
biology and human health.
Cases, material, and methods
Normal and affected animals
Animals affected with or heterozygous for BHZD were from a pedigree
established at Michigan State University. Semen from an affected bull,
“Denmark,” was used for artificial insemination to produce obligate
heterozygotes, which were then used in artificial insemination and embryo
transfer studies to establish a family segregating for BHZD as described [19].
Clinically normal Holsteins (98 females and 6 males) from a Michigan dairy
farm were included for DNA studies using leftover clotted blood from samples
taken for unrelated studies.
Isolation of DNA samples was carried out by use of a Trizol reagent
(Invitrogen) protocol on about 100 mg of tissue according to the manufacturer’s
instructions or by phenol–chloroform extraction after digestion of a clotted
blood sample in proteinase K based on a slight modification of the protocol
described [31]. The modification included the use of 200 μl of 5% SDS per 100–
200 mg of clotted blood sample to assist the lysis. Isolation of total RNA wascarried out using the Trizol reagent or the PureLink RNA Purification System
(both from Invitrogen). Intestinal tissues (ileum and jejunum) were used for the
RNA studies.
Sequence alignments
Sequence alignments were constructed using the Lasergene software
package of DNASTAR, Inc., as well as the BLAST algorithms of NCBI.
Primers were designed based on either trace sequences from the bovine genome
project (as in primer VYG1313F) or existing GenBank partial cDNA entry
AW47707 (as in primer VYG1170R) or from consensus primers based on
human (GI: 19115957) or mouse (GI: 27754010) sequences.
RT-PCR analysis and sequencing
Total RNA samples isolated from intestinal tissues of normal, heterozygous,
and affected bovine cases were reverse transcribed using either the M-MLV or
the Superscript III reverse transcriptase (Invitrogen). Consensus primers derived
either from alignment of human and mouse SLC39A4 coding regions or from
available bovine trace sequences were used to amplify the target regions from
normal, heterozygous, and affected bovine cDNA samples. The resulting
fragments were resolved on agarose gels and visualized under UV light after
ethidium bromide staining. Typical amplification reactions were prepared in a
526 V. Yuzbasiyan-Gurkan, E. Bartlett / Genomics 88 (2006) 521–52625-μl total reaction volume, with 5 μl (50–200 ng) cDNA template, 5 pmol of
each primer, 0.5 units of Taq polymerase (Invitrogen, Carlsbad, CA, USA), and
final concentrations of 80 μM dNTPs, 2 mM MgCl2, 20 mM Tris–HCl, and
50 mM KCl. When necessary, the PCR was adjusted to contain 5–10% DMSO
as indicated in Table 1. Cycling conditions were as follows: 94°C for 4 min; 35–
40 cycles at 94°C for 1 min, optimal annealing temperature (as indicated in
Table 1) for 1 min, 72°C for 1 min; followed by 72°C for 5 min. PCR products
were analyzed on agarose gels stained with ethidium bromide, then amplified
fragments were cut and purified using the QiaexII Gel Extraction kit (Qiagen).
The fragments were then sequenced either with automated sequencing or
manually with the amplification primers using the Thermo Sequenase
Radiolabeled Terminator Cycle Sequencing kit (USB Corp., Cleveland, OH,
USA) and 33P-labeled dideoxy-nucleotide triphosphates according to the
manufacturer’s protocol. Sequencing products were analyzed on 6% acrylamide
denaturing sequencing gels, dried, and exposed to Biomax MR Scientific
Imaging Film (Kodak, Rochester, NY, USA) for 48–72 h and developed.Acknowledgments
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